“Careful actions for” mid-year revision – Calling for the government-led initiative in promoting AMR countermeasures

株式会社薬事日報社から許諾を受けて、株式会社シーエムプラスが英語に翻訳しております。
オリジナルの正式言語は日本語であり、内容および解釈については日本語が優先されます。
With permission from Yakuji Nippo, Limited, CM Plus Corporation translated into English.
The original article is authored in Japanese, and the Japanese shall prevail in meaning in terms of content and interpretation.

【Government-Industry dialogue】
“Careful actions for” mid-year revision – Calling for the government-led initiative in promoting AMR countermeasures
November 18th, 2020

"Dialogue between government and industry for the creation of innovative drugs" was held on the 16th of Nov to exchange views on policy between Pharmaceutical industries and relevant ministers such as the Ministry of Health, Labor and Welfare and the Ministry of Education, Culture, Sports, Science and Technology. Governments interviewed pharmaceutical industries about future steps to strengthen innovation. There were ｍany opinions from the industries to call for environmental improvement which encourages innovations such as careful actions to the mid-year revision scheduled for April next year, preventing infectious diseases such as new coronavirus infections and Antimicrobial Resistance (AMR), and utilization of data and others.

(Continue to the next)

For this translated article in English, CM Plus Corporation shall have the copyright.
Unauthorized reproduction of posted articles, photos, diagrams, etc. is prohibited.
Copyright © 2020 LSMIP office / CM Plus Singapore Pte. Ltd.